November 1, 2014

Senior Consultant Jill E. Sackman, D.V.M., Ph.D., and Research Analyst Mike Kuchenreuther, Ph.D., provide an in-depth look at recent developments in the German pharmaceutical market in Germany Post AMNOG: Insights for BioPharma, published November 2014, by BioPharm International.

Jill and Mike identify pricing and reimbursement challenges and discuss strategies manufacturers should consider for sustainable success.  Manufacturers prepared for benefit assessment and the negotiation processes will be best positioned for success.